Organization | Bone and Joint Clinic of Baton Rouge

Bone and Joint Clinic of Baton Rouge Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2011

NCT02285725

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Bone and Joint Clinic of Baton Rouge | Joseph E. Broyles

Active Ingredients

Drugs in Other Trials (4)

autologous bone marrow (1 trial)

bone marrow cells (1 trial)

hyaluronic acid (1 trial)

platelet rich plasma (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 2
# of Trial APIs: 4